This pharmaceutical company specializes in oncology and has nearly two decades of experience developing generic and specialty drugs. They focus on delivering affordable, world-class chemotherapy medications across a wide range of therapeutic areas. Their robust research and development team possesses expertise in complex drug molecule development, serving diverse markets globally. With over 35 developed generics and specialty drugs, they have filed over 40 dossiers across 25 countries in emerging markets. The company is committed to expanding its presence in the oncology therapeutic area within emerging markets.

Established in 2004, this pharmaceutical manufacturer specializes in producing liquid orals, cephalosporin tablets, capsules, dry powder syrups, dry powder injections, liquid injectables (SVP) in ampoules and vials, and lyophilized injections. As a CTD dossier owner and manufacturer, it holds multiple GMP certifications, including EU GMP, ISO 9001:2015 (BVQI), WHO-GMP, and cGMP. Additionally, its facilities are approved by national drug authorities in countries such as Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe, Cambodia, Vietnam, Malawi, Namibia, Nigeria, Côte d'Ivoire, the Philippines, and Peru. The manufacturer operates advanced production lines adhering to stringent GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across over 50 countries globally, with 292 registered products and an additional 210 products under registration.

This globally operating pharmaceutical company focuses on developing and manufacturing a broad range of affordable medications. They specialize in both prescription and over-the-counter drugs, including oncology treatments, antibacterials, injectables (both specialty and large volume), ophthalmic products, dermatological preparations, and veterinary pharmaceuticals. Their product portfolio also includes unique niche drugs and orphan products, showcasing their commitment to addressing diverse medical needs. The company boasts state-of-the-art manufacturing facilities located across several regions, adhering to strict quality standards recognized by international regulatory bodies like the WHO GMP, US FDA, and MCC. Their extensive global reach spans over 45 countries in Asia, Africa, Latin America, CIS, Europe, Australia, and the Pacific Ocean. The company's focus on research and development, coupled with its global manufacturing capabilities and commitment to quality, positions them as a key player in the international pharmaceutical market.